Michael König

Mr. Michael KÖNIG is Adviser for Platform Regulation and the Digital Markets Act in the European Commission’s Directorate-General for Communications Networks, Content and Technology (DG CNECT). He was front line negotiator for the Digital Markets Act and will oversee its implementation in DG CNECT.

Before taking up his position in DG CNECT, Mr König was several years Deputy Head of Unit in the European Commission’s Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (GROW) in the unit responsible for Online services. He was primarily responsible for B2B relations regarding online platforms and negotiated the Regulation on fairness in platform-to-business relations (P2B Regulation).

Mr König joined the European Commission in 2001 in the Directorate-General for Competition. His assignments included a position as advisor to Directorate-General’s top management and a secondment to the OECD, before he joined the Internal Market Directorate-General in 2008. There he held positions in various policy areas including intellectual property, financial services and public procurement.

Before joining the Commission, Mr. König worked for several years in the German Competition Authority and an international law firm.

Mr. König graduated in Law and Economics, and holds a PhD degree in Competition Law.

When AI Helps Generate Inventions, Who Is the Inventor?

By Andrei Iancu and Rama Elluru This commentary from the CSIS-SCSP Task Force on IP in the AI Era was originally published in the Special Competitive Studies Project’s Substack on February 15, 2024. With roots in the U.S. constitution, patent rights provide an exclusive property right in new inventions like drugs,
Read More

Standard Essential Patents and European Economic Security

By Kirti Gupta and Chris Borges On April 27, 2023, the European Commission published a draft proposal on standard essential patents (SEPs) seeking to address the perceived lack of transparency and predictability in the licensing of SEPs. The commission proposes the creation of a competence center within the European Union Intellectual
Read More

Proposed Federal Use of March-in Rights Would Weaken American Innovation

By Sujai Shivakumar and Thomas Howell   The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of
Read More